priyanka chigurupati

City-based pharma player Granules India Limited, on Monday said its wholly owned US subsidiary, Granules Pharmaceuticals Inc (GPI) has received three observations from the US drug regulator, US Food & Drug Administration (USFDA) for its facility located in Chantilly, Virginia, USA.

Trump's new 100% pharma levy primarily targets branded and patented medicines, potentially impacting Sun Pharma and Biocon's US sales. While most Indian generic firms anticipate business as usual, some may shift high-value production to US facilities or diversify markets.